PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL Jun 16, 2025 07:00AM
FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER Sep 19, 2024 07:13PM
FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US Jan 17, 2024 09:31PM
AACR OVARIAN CANCER CONFERENCE PRESENTATION Oct 9, 2023 03:18AM
AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer May 29, 2023 04:51AM